RANDI KILLIAN: Open Payments
NPI 1093364648 · PLAINSBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 20 payments from 6 companies in 2025. Trend: 2023 $30 · 2024 $136 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 3 | $149 |
| GlaxoSmithKline, LLC. | 8 | $147 |
| CSL Behring | 3 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Hikma Pharmaceuticals USA | 1 | $14 |
Products named: Xhance, NUCALA, Andembry, Hizentra, CUVITRU, DUPIXENT, TAKHZYRO, Ryaltris.
Industry payments across NJ — which companies pay providers there.
